Vaxart, Inc.To Present At Phacilitate’s VAX 1-2-1 In Amsterdam On May 20, 2015
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a privately held, clinical-stage company developing vaccines that are administered by tablet rather than by injection, today announced that Vaxart CEO Wouter Latour, MD, will present a corporate overview at Phacilitate’s VAX 1-2-1 in Amsterdam on Wednesday, May 20, 2015 at 3:30pm Central European Time. Dr. Latour will also take part in a panel discussion on vaccines on the same day, and he will be available to participate in one-on-one meetings during the meeting.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.